CVS vs TERN · P/E 16, rev $402.07B vs $6.12B cap
CVS Health Corp (CVS) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. TERN currently screens at market cap $6.12B.
Not investment advice. Open the CVS and TERN stock pages for the full models.
Not investment advice.